PharmaSGP Holding SE (PSG.DE) XETRA

Currency In EUR

AD

Valuation

Market Cap296.85M
Enterprise Value271.32M
P/E Ratio17.58
PEG Ratio1.78
Price/Sales Ratio2.81
Price/Book Ratio10.77
Enterprise/Revenue2.59
Enterprise/EBITDA7.79

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.16
Operating Margin0.23
AD

Management Effectiveness

Return On Assets0.17
Return On Equity0.54

Income Statement

Revenue118.84M
Revenue/Share10.01
Gross Profit107.99M
EBITDA39.6M
Net Income19.54M
Diluted EPS1.65

Balance Sheet

Total Cash29.32M
Total Cash/Share2.23
Total Debt860,000
Total Debt/Equity0.03
Current Ratio2.33
Book Value Per Share2.69

Price History

52-Week Change51.04
52-Week High30
52-Week Low19
Moving Average 50 Days28.52
Moving Average 200 Days26.1

Statistics

Average Volume5,399
Shares Outstanding11.51M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.05
Trailing Annual Dividend Yield0.17
Payout Ratio0.83
Last Split FactorN/A
Last Split DateN/A
AD